Nashville, Tennessee… Delano, a Tennessee man, has sued Abbott Laboratories in federal court stating that Humira, an arthritis drug, caused him to contract a life-threatening fungal infection.
The complaint states that Abbott failed to print warnings that Humira places patients at risk for histoplasmosis and other “opportunistic infections” by depressing the immune system. Delano claims that Abbott “achieved blockbuster sales” of Humira “by ignoring or explaining away safety signals, refusing to provide appropriate warnings about dangerous side effects, publishing and disseminating misleading scientific articles about Humira’s safety, and overly aggressive marketing.”
“In order to compete more effectively against (competitor drugs) Enbrel and Remicade, Abbott delayed warning about histoplasmosis or other opportunistic infections….Indeed, even when the FDA exercised new legal authority on Sept. 4, 2008, to ‘require’ warnings within 30 days, Abbott stalled until late 2009 and early 2010 – after Delano received this first injections and nearly died. This is unconscionable behavior.”
A study led by the Mayo Clinic found patients taking Humira or Remicade face triple the risk of developing several kinds of cancer and double the risk of getting serious infections. Abbott failed to warn physicians and patients of these risks.
If you or a loved one experienced any complications associated with the use of Humira, please visit our website for more information.
